BRPI0509210A - uso de gaboxadol, e, métodos para tratar função respiratória enfraquecida, e apnéia do sono - Google Patents

uso de gaboxadol, e, métodos para tratar função respiratória enfraquecida, e apnéia do sono

Info

Publication number
BRPI0509210A
BRPI0509210A BRPI0509210-8A BRPI0509210A BRPI0509210A BR PI0509210 A BRPI0509210 A BR PI0509210A BR PI0509210 A BRPI0509210 A BR PI0509210A BR PI0509210 A BRPI0509210 A BR PI0509210A
Authority
BR
Brazil
Prior art keywords
gaboxadol
sleep apnea
respiratory function
methods
treating impaired
Prior art date
Application number
BRPI0509210-8A
Other languages
English (en)
Inventor
Jonas Lundahl
Bjarke Ebert
Jan Hedner
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34962889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0509210(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BRPI0509210A publication Critical patent/BRPI0509210A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

USO DE GABOXADOL, E, MéTODOS PARA TRATAR FUNçãO RESPIRATóRIA ENFRAQUECIDA, E APNéIA DO SONO A presente invenção refere-se a um método para tratar função respiratória enfraquecida em um paciente humano sofrendo de apnéia do sono, tal como apnéia central do sono ou apnéia obstrutiva do sono, compreendendo administrar ao citado paciente uma quantidade eficaz de gaboxadol por dia.
BRPI0509210-8A 2004-04-02 2005-03-31 uso de gaboxadol, e, métodos para tratar função respiratória enfraquecida, e apnéia do sono BRPI0509210A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55909604P 2004-04-02 2004-04-02
DKPA200400540 2004-04-02
PCT/DK2005/000222 WO2005094820A1 (en) 2004-04-02 2005-03-31 Treatment of impaired respiratory function with gaboxadol

Publications (1)

Publication Number Publication Date
BRPI0509210A true BRPI0509210A (pt) 2007-08-28

Family

ID=34962889

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509210-8A BRPI0509210A (pt) 2004-04-02 2005-03-31 uso de gaboxadol, e, métodos para tratar função respiratória enfraquecida, e apnéia do sono

Country Status (9)

Country Link
US (2) US20080269278A1 (pt)
EP (1) EP1734956A1 (pt)
JP (1) JP2007530604A (pt)
AU (1) AU2005229493A1 (pt)
BR (1) BRPI0509210A (pt)
CA (1) CA2561883A1 (pt)
MX (1) MXPA06011325A (pt)
NO (1) NO20064964L (pt)
WO (1) WO2005094820A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3795156A1 (en) 2014-06-06 2021-03-24 Ovid Therapeutics, Inc. Pharmaceutical composition for treating angelman syndrome
US9682069B2 (en) 2015-07-17 2017-06-20 Ovid Therapeutics Inc Methods of treating Dravet syndrome
CN108024997A (zh) 2015-07-17 2018-05-11 奥维德医疗公司 用加波沙朵治疗发育障碍的方法
US9399034B1 (en) 2015-08-11 2016-07-26 Ovid Therapeutics Inc Methods of sedation during critical care treatment
KR20230050474A (ko) 2016-08-11 2023-04-14 오비드 테라퓨틱스 인크. 간질 장애의 치료를 위한 방법 및 조성물
EP3528807A4 (en) * 2016-11-22 2020-06-17 Ovid Therapeutics Inc METHOD FOR TREATING DEVELOPMENT DISORDERS AND / OR FALLS WITH FLUPIRTIN
US10071083B2 (en) 2017-02-03 2018-09-11 Ovid Therapeutics Inc Use of gaboxadol in the treatment of tinnitus
US20180338959A1 (en) 2017-05-24 2018-11-29 Ovid Therapeutics Inc. Treatment of depressive disorders
CA3071939A1 (en) * 2017-08-04 2019-02-07 Ovid Therapeutics Inc. Use of gaboxadol in the treatment of diabetes and related conditions
EP3833351A4 (en) 2018-09-20 2021-10-13 Ovid Therapeutics Inc. USE OF GABOXADOL TO TREAT TOURETTE SYNDROME, TICKS, AND STUTTERS
KR20210110585A (ko) 2018-11-21 2021-09-08 썰테고 테라퓨틱스 아이엔씨. 자살의 위험을 감소시키고 우울증의 신속한 완화를 위한 가복사돌
MX2021007224A (es) 2018-12-17 2021-09-23 Ovid Therapeutics Inc Uso de gaboxadol para el tratamiento del trastorno del sue?o vigilia que no es de 24 horas.
US11364228B2 (en) 2019-12-18 2022-06-21 Ovid Therapeutics Inc. Gaboxadol for therapeutic treatment of 1p36 deletion syndrome
IL298334A (en) 2020-05-20 2023-01-01 Certego Therapeutics Inc Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
US6555564B1 (en) * 1999-03-04 2003-04-29 The Board Of Trustees Of The University Of Illinois Neuropharmacological treatments of sleep-related breathing disorders
AR045540A1 (es) * 2003-09-05 2005-11-02 Lundbeck & Co As H Metodo de elaboracion de 4,5,6,7 tetrahidroisoxazol [5,4-c] piridin-3-ol (thip)

Also Published As

Publication number Publication date
US20100093787A1 (en) 2010-04-15
MXPA06011325A (es) 2006-12-15
NO20064964L (no) 2006-10-30
CA2561883A1 (en) 2005-10-13
EP1734956A1 (en) 2006-12-27
JP2007530604A (ja) 2007-11-01
US20080269278A1 (en) 2008-10-30
AU2005229493A1 (en) 2005-10-13
WO2005094820A1 (en) 2005-10-13

Similar Documents

Publication Publication Date Title
WO2008048471A3 (en) Obstructive sleep apnea treatment devices, systems and methods
WO2006023702A3 (en) Method for treating sleep related breathing disorders with setiptiline
DE602006007093D1 (de) Kombinationstherapie zur Behandlung von Diabetes und dadurch bedingten Leiden sowie zur Behandlung von mittels Erhöhung des GLP-1-Spiegels im Blut verbesserten Leiden
MX2009011540A (es) Tratamiento de desordenes de movimiento con el uso combinado de toxina botulinica y estimulacion del musculo.
WO2008039921A3 (en) Apparatus and method for treating obstructive sleep apnea
MY174080A (en) Use of dpp iv inhibitors
MX2012007813A (es) Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional.
UA90048C2 (ru) Кондиционированная композиция и способ ее получения
WO2010002936A3 (en) Systems, methods and devices for paired plasticity
BRPI0510043A (pt) método de tratamento de dor neuropática usando antagonista de receptor crth2
BRPI0510094A (pt) uso de flibanserina no tratamento pré-menstrual e outros distúrbios sexuais femininos
HK1202776A1 (en) Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapy
IL192101A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
WO2011146926A3 (en) Systems and methods for treatment of sleep apnea
WO2011116384A3 (en) Systems and methods for treatment of sleep apnea
ATE538800T1 (de) Kombinationstherapie zur krebsbehandlung
WO2011044523A3 (en) Compositions and methods for treating obesity
NO20064964L (no) Behandling av svekket respiratorisk funksjon
WO2012075503A3 (en) Systems and methods for treatment of sleep apnea
PT1261333E (pt) Utilizacao de topiramato para o tratamento e diagnostico de transtorno do sono relacionado com a respiracao e meios para realizar o metodo e o diagnostico
ATE410163T1 (de) Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens
IL198395A0 (en) Methods for treatment of cochlear and vestibular disorders
MX2009003676A (es) Compuestos s-nitrosotiol y derivados relacionados.
GB0405381D0 (en) A method and means for treating heart failure
MX2008002456A (es) Uso de ambroxol para el tratamiento de infecciones por rinovirus.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.